<code id='30EFBE7090'></code><style id='30EFBE7090'></style>
    • <acronym id='30EFBE7090'></acronym>
      <center id='30EFBE7090'><center id='30EFBE7090'><tfoot id='30EFBE7090'></tfoot></center><abbr id='30EFBE7090'><dir id='30EFBE7090'><tfoot id='30EFBE7090'></tfoot><noframes id='30EFBE7090'>

    • <optgroup id='30EFBE7090'><strike id='30EFBE7090'><sup id='30EFBE7090'></sup></strike><code id='30EFBE7090'></code></optgroup>
        1. <b id='30EFBE7090'><label id='30EFBE7090'><select id='30EFBE7090'><dt id='30EFBE7090'><span id='30EFBE7090'></span></dt></select></label></b><u id='30EFBE7090'></u>
          <i id='30EFBE7090'><strike id='30EFBE7090'><tt id='30EFBE7090'><pre id='30EFBE7090'></pre></tt></strike></i>

          focus

          focus

          author:entertainment    Page View:291
          King Street Properties’ Pathway Devens campus. -- biotech coverage from STAT
          Pat Greenhouse/Globe Staff

          MORRISVILLE, N.C. — Ten minutes from the Raleigh airport, the future of biotech is under construction.

          On either side of a new stretch of four-lane highway sit two $1 billion biomanufacturing campuses, which will bring a combined 2.5 million square feet of research and development and advanced manufacturing space to a region that has become the No. 1 place where North America makes prescription drugs.

          advertisement

          One campus, called Pathway Triangle, is being built by a developer from Boston, King Street Properties. King Street — which has projects in Cambridge, Waltham, Allston, and Lexington — is building a similarly vast biomanufacturing campus in Devens. But these days it also sees a land of opportunity 700 miles to the south, in North Carolina.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          After affirmative action ruling, medical educators look to 'holistic review'
          After affirmative action ruling, medical educators look to 'holistic review'

          AnnaMoneymaker/GettyImagesAfterhavingadaytoreadthroughtheSupremeCourt’sdecisiononaffirmativeaction,s

          read more
          Despite FDA concern, risk that CAR
          Despite FDA concern, risk that CAR

          EngineeredreceptorsonthesurfaceofaT-lymphocytebindtoaleukemiacell.AdobeTheannouncementonTuesdaythatt

          read more
          Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen
          Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

          1:19Ademonstratorrunsonthethirdnightofprotestssparkedbythefatalpoliceshootingofa17-year-olddriverint

          read more

          FDA investigates CAR

          TheFDAislookingintoadverseeventsinvolvinganumberofCAR-Ttherapies,includingBreyanzi.Illustration:STAT